Association of candidate variants with NRM and RM
Chr . | Gene . | SNP . | Alleles* . | End point . | Genome . | Model . | MAF† . | Discovery results . | Replication results . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
P . | HR (95% CI) . | P . | HR (95% CI) . | Power, %‡ . | ||||||||
9 | CD274 | rs10975123 | C/T | NRM | Recipient | Recessive | 0.18 | .00004 | 2.05 (1.5-2.8) | .46 | 0.84 (0.5-1.4) | 39 |
9 | CD274 | rs10975123 | C/T | NRM | Recipient | Allelic | 0.18 | .0008 | 1.24 (1.1-1.4) | .99 | 1.00 (0.9-1.2) | 100 |
6 | HLA-DOA | rs429916 | C/A | NRM | Recipient | Recessive | 0.07 | .004 | 2.91 (1.6-5.4) | .19 | 0.34 (0.05-2.4) | 6 |
6 | MICA | rs1051792 | G/A | NRM | Donor | Allelic | 0.27 | .002 | 0.84 (0.8-0.9) | .02 | 0.85 (0.7-1.0) | 100 |
5 | IL12B | rs3212227 | T/G | NRM | Donor | Recessive | 0.21 | .005 | 0.56 (0.4-0.9) | .39 | 1.21 (0.8-1.8) | 48 |
3 | CCR5 | rs1800023 | A/G | RM | Donor | Dominant | 0.36 | .002 | 1.29 (1.1-1.5) | .14 | 1.16 (1.0-1.4) | 100 |
Chr . | Gene . | SNP . | Alleles* . | End point . | Genome . | Model . | MAF† . | Discovery results . | Replication results . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
P . | HR (95% CI) . | P . | HR (95% CI) . | Power, %‡ . | ||||||||
9 | CD274 | rs10975123 | C/T | NRM | Recipient | Recessive | 0.18 | .00004 | 2.05 (1.5-2.8) | .46 | 0.84 (0.5-1.4) | 39 |
9 | CD274 | rs10975123 | C/T | NRM | Recipient | Allelic | 0.18 | .0008 | 1.24 (1.1-1.4) | .99 | 1.00 (0.9-1.2) | 100 |
6 | HLA-DOA | rs429916 | C/A | NRM | Recipient | Recessive | 0.07 | .004 | 2.91 (1.6-5.4) | .19 | 0.34 (0.05-2.4) | 6 |
6 | MICA | rs1051792 | G/A | NRM | Donor | Allelic | 0.27 | .002 | 0.84 (0.8-0.9) | .02 | 0.85 (0.7-1.0) | 100 |
5 | IL12B | rs3212227 | T/G | NRM | Donor | Recessive | 0.21 | .005 | 0.56 (0.4-0.9) | .39 | 1.21 (0.8-1.8) | 48 |
3 | CCR5 | rs1800023 | A/G | RM | Donor | Dominant | 0.36 | .002 | 1.29 (1.1-1.5) | .14 | 1.16 (1.0-1.4) | 100 |
Chr, chromosome; CI, confidence interval; HR, hazard ratio.
Plus strand major/minor alleles.
MAF in the samples used for the test.
Post hoc power estimates to detect an HR ≥1.5 or ≤0.67 at a 2-sided significance level of .05 were based on the estimated standard error of the log HR in the replication cohort.